Comparative Efficacy of Pharmacological Agents for Moderate-Severe Crohn's Disease in Patients with Prior Exposure to Anti-TNF Agents: A Network Meta-Analysis

被引：0
|
作者：
Singh, Siddharth [1 ]
Fumery, Mathurin [2 ]
Dulai, Parambir [3 ]
Murad, Mohammad [4 ]
Sandborn, William [3 ]
机构：
[1] UCSD Med Ctr, San Diego, CA USA
[2] Gastroenterol Unit, Amiens, Somme, France
[3] Univ Calif San Diego, La Jolla, CA USA
[4] Mayo Clin, Rochester, MN USA
来源：
INFLAMMATORY BOWEL DISEASES | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P-122
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [1] Comparative Efficacy of Pharmacological Agents for Moderate-Severe Ulcerative Colitis in Patients with Prior Exposure to Anti-TNF Agents: A Network Meta-Analysis
    Singh, Siddharth
    Fumery, Mathurin
    Dulai, Parambir
    Murad, Mohammad
    Sandborn, William
    [J]. INFLAMMATORY BOWEL DISEASES, 2017, 23 : S43 - S44
  • [2] Efficacy of Anti-TNF agents in luminal crohn's disease: A meta-analysis
    Deltenre, Pierre
    Peyrin-Biroulet, Laurent
    Sandborn, William J.
    Colombel, Jean-Frederic
    [J]. GASTROENTEROLOGY, 2007, 132 (04) : A146 - A146
  • [3] Systematic review with network meta-analysis: the efficacy of anti-TNF agents for the treatment of Crohn's disease
    Stidham, R. W.
    Lee, T. C. H.
    Higgins, P. D. R.
    Deshpande, A. R.
    Sussman, D. A.
    Singal, A. G.
    Elmunzer, B. J.
    Saini, S. D.
    Vijan, S.
    Waljee, A. K.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (12) : 1349 - 1362
  • [4] Comparing the Effectiveness of Anti-TNF Agents for the Treatment of Crohn's Disease: a Bayesian Network Meta-Analysis
    Stidham, Ryan W.
    Lee, Terrence
    Higgins, Peter D.
    Deshpande, Amar R.
    Sussman, Daniel A.
    Singal, Amit G.
    Elmunzer, B. Joseph J.
    Saini, Sameer D.
    Vijan, Sandeep
    Waljee, Akbar K.
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S202 - S202
  • [5] Experience with Ustekinumab in Mexican Patients with Moderate-Severe Anti-TNF Resistant Crohn's Disease
    Paz Delgadillo, Jonathan
    Flores Rendon, Ricardo
    Miranda Cordero, Maria
    Bosques Padilla, Francisco
    Martinez Vazquez, Manuel
    [J]. INFLAMMATORY BOWEL DISEASES, 2016, 22 : S39 - S39
  • [6] Anti-TNF agents in Crohn's disease
    Van Assche, G
    Rutgeerts, P
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (01) : 103 - 111
  • [7] Natalizumab is Effective in the Treatment of Moderate to Severe Crohn's Disease Unresponsive to Anti-TNFα Agents
    Elvanides, Harry S.
    Burchett, Mary
    Ingram, Karen R.
    Annis, Kim
    Arsenescu, Razvan I.
    de Villiers, Willem J.
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S698 - S698
  • [8] Anti-TNFα agents are the best choice in preventing postoperative Crohn's disease: A meta-analysis
    Eros, Adrienn
    Farkas, Nelli
    Hegyi, Peter
    Szabo, Aniko
    Balasko, Marta
    Veres, Gabor
    Czako, Laszlo
    Bajor, Judit
    Alizadeh, Hussain
    Rakonczay, Zoltan
    Miko, Alexandra
    Habon, Tamas
    Eross, Balint
    Berczi, Balint
    Sarlos, Patricia
    [J]. DIGESTIVE AND LIVER DISEASE, 2019, 51 (08) : 1086 - 1095
  • [9] Risk of lymphoma associated with anti-TNF agents for the treatment of Crohn's disease: A meta-analysis
    Siegel, Corey A.
    Marden, Sadie M.
    Persing, Sarah M.
    Larson, Robin J.
    Sands, Bruce E.
    [J]. GASTROENTEROLOGY, 2008, 134 (04) : A144 - A144
  • [10] Anti-TNF Agents Decrease Imaging and Radiation Exposure in Patients with Crohn's Disease
    Patil, Seema
    Rustgi, Ankur
    Quezada, Sandra
    Flasar, Mark
    Vandermeer, Fauzia
    Cross, Raymond
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S451 - S451
12345